Complex Task to Estimate Immune Responses to Various Poliovirus Vaccines and Vaccination Schedules

Overview

Journal Lancet Infect Dis

Specialty Infectious Diseases

Date 2019 Jul 28

PMID 31350191

Authors

Khalequ Zaman

Abhijeet Anand

Affiliations

Soon will be listed here.

References

Anand A, Zaman K, Estivariz C, Yunus M, Gary H, Weldon W . Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial. Vaccine. 2015; 33(48):6816-22. PMC: 10423714. DOI: 10.1016/j.vaccine.2015.09.039. View

Resik S, Tejeda A, Sutter R, Diaz M, Sarmiento L, Alemani N . Priming after a fractional dose of inactivated poliovirus vaccine. N Engl J Med. 2013; 368(5):416-24. DOI: 10.1056/NEJMoa1202541. View

Shimizu H . Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan. Vaccine. 2014; 34(16):1975-85. DOI: 10.1016/j.vaccine.2014.11.015. View

Hird T, Grassly N . Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 2012; 8(4):e1002599. PMC: 3330118. DOI: 10.1371/journal.ppat.1002599. View

Thompson K, Pallansch M, Tebbens R, Wassilak S, Kim J, Cochi S . Preeradication vaccine policy options for poliovirus infection and disease control. Risk Anal. 2013; 33(4):516-43. PMC: 7941951. DOI: 10.1111/risa.12019. View

Bahl S, Verma H, Bhatnagar P, Haldar P, Satapathy A, Kumar K . Fractional-Dose Inactivated Poliovirus Vaccine Immunization Campaign - Telangana State, India, June 2016. MMWR Morb Mortal Wkly Rep. 2016; 65(33):859-63. DOI: 10.15585/mmwr.mm6533a5. View

Bhaumik S, Kulkarni R, Weldon W, Silveira E, Ahmed H, Gunisetty S . Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models: Support for at least 2 Doses. Clin Infect Dis. 2018; 67(suppl_1):S66-S77. PMC: 6206122. DOI: 10.1093/cid/ciy634. View

Robertson S, Traverso H, Drucker J, Rovira E, Fabre-Teste B, Sow A . Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine. Lancet. 1988; 1(8591):897-9. DOI: 10.1016/s0140-6736(88)91711-4. View

Estivariz C, Pallansch M, Anand A, Wassilak S, Sutter R, Wenger J . Poliovirus vaccination options for achieving eradication and securing the endgame. Curr Opin Virol. 2013; 3(3):309-15. PMC: 10395005. DOI: 10.1016/j.coviro.2013.05.007. View

10.

Macklin G, Grassly N, Sutter R, Mach O, Bandyopadhyay A, Edmunds W . Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis. Lancet Infect Dis. 2019; 19(10):1121-1128. DOI: 10.1016/S1473-3099(19)30301-9. View